Catheter Precision Inc [AMEX: VTAK] gained 2.59% or 0.01 points to close at $0.24 with a heavy trading volume of 10787029 shares.
It opened the trading session at $0.234, the shares rose to $0.26 and dropped to $0.226, the range by which the price of stock traded the whole day. The daily chart for VTAK points out that the company has recorded -48.82% loss over the past six months.
If we look at the average trading volume of 14.21M shares, VTAK reached to a volume of 10787029 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Catheter Precision Inc [VTAK]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for VTAK shares is $2.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on VTAK stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Piper Jaffray have made an estimate for Catheter Precision Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on August 13, 2019. While these analysts kept the previous recommendation, Maxim Group raised their target price to Buy. The new note on the price target was released on November 02, 2018, representing the official price target for Catheter Precision Inc stock.
The Price to Book ratio for the last quarter was 0.28, with the Price to Cash per share for the same quarter was set at 0.04.
Trading performance analysis for VTAK stock
Catheter Precision Inc [VTAK] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 0.85. With this latest performance, VTAK shares dropped by -27.04% in over the last four-week period, additionally sinking by -48.82% over the last 6 months – not to mention a drop of -47.23% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for VTAK stock in for the last two-week period is set at 47.05, with the RSI for the last a single of trading hit 0.0247, and the three-weeks RSI is set at 0.0372 for Catheter Precision Inc [VTAK]. The present Moving Average for the last 50 days of trading for this stock 0.2608, while it was recorded at 0.2283 for the last single week of trading, and 0.3685 for the last 200 days.
Catheter Precision Inc [VTAK]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Catheter Precision Inc [VTAK] shares currently have an operating margin of -2512.06% and a Gross Margin at -345.74%. Catheter Precision Inc’s Net Margin is presently recorded at -4817.26%.
Catheter Precision Inc (VTAK) Capital Structure & Debt Analysis
According to recent financial data for Catheter Precision Inc. ( VTAK), the Return on Equity (ROE) stands at -136.26%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -68.20%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Catheter Precision Inc’s Return on Invested Capital (ROIC) is -126.65%, showcasing its effectiveness in deploying capital for earnings.
Catheter Precision Inc (VTAK) Efficiency & Liquidity Metrics
Based on Catheter Precision Inc’s (VTAK) latest financial statements, the Debt-to-Equity Ratio is 1.53%, indicating its reliance on debt financing relative to shareholder equity.
Catheter Precision Inc (VTAK) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Catheter Precision Inc. (VTAK) effectively leverages its workforce, generating an average of -$1053181.82 per employee. The company’s liquidity position is robust, with a Current Ratio of 0.21% and a Quick Ratio of 0.19%, indicating strong ability to cover short-term liabilities.
An analysis of Institutional ownership at Catheter Precision Inc [VTAK]
There are presently around $4.67%, or 5.08%% of VTAK stock, in the hands of institutional investors.
